Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
VANCOUVER, British Columbia and AUSTIN, Texas, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Semiconductor Holdings Inc. (“InspireSemi” or the “Company”), a chip design company that provides...
-
Nokia OyjPörssitiedote10.01.2025 klo 22.30 Nokia Oyj: Omien osakkeiden takaisinosto 10.01.2025 Espoo – Nokia Oyj (LEI: 549300A0JPRWG1KI7U06) on 10.01.2025 hankkinut omia osakkeitaan (ISIN...
-
Nokia CorporationStock Exchange Release10 January 2025 at 22:30 EET Nokia Corporation: Repurchase of own shares on 10.01.2025 Espoo, Finland – On 10 January 2025 Nokia Corporation (LEI:...
-
Transaction in Own Shares 10 January, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 10 January 2025 it purchased the following number of Shares for...
-
Sanoma Oyj, pörssitiedote, 10.01.2025 klo 18.30 SANOMA OYJ: OMIEN OSAKKEIDEN HANKINTA 10.01.2025 Nasdaq Helsinki Oy: Päivämäärä10.01.2025 PörssikauppaOsto OsakelajiSANOMA Osakemäärä, kpl9...
-
Sanoma Corporation, Stock exchange release, 10 January 2025 at 18:30 EET SANOMA CORPORATION: ACQUISITION OF OWN SHARES 10 January 2025Nasdaq Helsinki Ltd: Date10 January 2025 Exchange...
-
BRAINTREE, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under...
-
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...
-
Private placement to radiopharmaceutical industry leader Lantheus, for US$5.0 millionPlacement at A$0.060 per share, representing a premium of 150% to the last closing price of A$0.024Lantheus...
-
COPENHAGEN, Denmark, January 10, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced...